Challenging management of hepatitis B infection in ankylosing spondylitis patients in an endemic area during immunosuppressive therapy
Rev. Soc. Bras. Med. Trop
;
52: e20180386, 2019. graf
Article
Dans Anglais
| LILACS
| ID: biblio-990436
ABSTRACT
Abstract Hepatitis B infection is a global health issue. When considering patients with rheumatic diseases, this is no different. By using immunosuppressant drugs, such as DMARDs and biologics, viral reactivation is possible, leading to serious consequences on the patient. We report 3 cases of association between ankylosing spondylitis and hepatitis B with the use of immunosuppressant drugs. Case 1 was a patient with previous HBV infection using DMARD. Cases 2 and 3 were patients chronically infected by HBV during immunosuppressant therapy. The management of HBV infection during immunosuppressant therapy is challenging and needs multidisciplinary support.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Pelvispondylite rhumatismale
/
Activation virale
/
Antirhumatismaux
/
Hépatite B
/
Immunosuppresseurs
Limites du sujet:
Femelle
/
Humains
/
Grossesse
langue:
Anglais
Texte intégral:
Rev. Soc. Bras. Med. Trop
Thème du journal:
Médecine tropicale
Année:
2019
Type:
Article
Pays d'affiliation:
Brésil
Institution/Pays d'affiliation:
Hospital Universitário Getúlio Vargas/BR
/
Universidade Federal do Amazonas/BR
/
Universidade Nilton Lins/BR
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS